EDAP TMS S.A (EDA) - Total Assets
Based on the latest financial reports, EDAP TMS S.A (EDA) holds total assets worth €79.00 Million EUR (≈ $92.36 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See EDAP TMS S.A (EDA) net assets for net asset value and shareholders' equity analysis.
EDAP TMS S.A - Total Assets Trend (2016–2025)
This chart illustrates how EDAP TMS S.A's total assets have evolved over time, based on quarterly financial data.
EDAP TMS S.A - Asset Composition Analysis
Current Asset Composition (December 2025)
EDAP TMS S.A's total assets of €79.00 Million consist of 72.4% current assets and 27.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 25.9% |
| Accounts Receivable | €21.29 Million | 27.0% |
| Inventory | €12.83 Million | 16.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.80 Million | 2.3% |
| Goodwill | €2.83 Million | 3.6% |
Asset Composition Trend (2016–2025)
This chart illustrates how EDAP TMS S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of EDAP TMS S.A.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EDAP TMS S.A's current assets represent 72.4% of total assets in 2025, a decrease from 86.9% in 2016.
- Cash Position: Cash and equivalents constituted 25.9% of total assets in 2025, down from 47.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, unchanged from 5.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 27.0% of total assets.
EDAP TMS S.A Competitors by Total Assets
Key competitors of EDAP TMS S.A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
EDAP TMS S.A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.54 | 1.85 | 2.26 |
| Quick Ratio | 1.19 | 1.36 | 1.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €20.02 Million | €33.31 Million | €24.29 Million |
EDAP TMS S.A - Advanced Valuation Insights
This section examines the relationship between EDAP TMS S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.63 |
| Latest Market Cap to Assets Ratio | 1.34 |
| Asset Growth Rate (YoY) | -8.2% |
| Total Assets | €79.00 Million |
| Market Capitalization | $105.70 Million USD |
Valuation Analysis
Above Book Valuation: The market values EDAP TMS S.A's assets above their book value (1.34x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: EDAP TMS S.A's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for EDAP TMS S.A (2016–2025)
The table below shows the annual total assets of EDAP TMS S.A from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €79.00 Million ≈ $92.36 Million |
-8.21% |
| 2024-12-31 | €86.06 Million ≈ $100.62 Million |
-5.99% |
| 2023-12-31 | €91.55 Million ≈ $107.03 Million |
-9.47% |
| 2022-12-31 | €101.12 Million ≈ $118.22 Million |
+30.94% |
| 2021-12-31 | €77.23 Million ≈ $90.29 Million |
+39.92% |
| 2020-12-31 | €55.19 Million ≈ $64.53 Million |
+4.00% |
| 2019-12-31 | €53.07 Million ≈ $62.04 Million |
+8.88% |
| 2018-12-31 | €48.74 Million ≈ $56.98 Million |
+3.93% |
| 2017-12-31 | €46.90 Million ≈ $54.83 Million |
+0.66% |
| 2016-12-31 | €46.59 Million ≈ $54.47 Million |
-- |
About EDAP TMS S.A
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU s… Read more